OCT 31, 2018 2:46 PM PDT

New Drug Target For a Rare Lymphoma

WRITTEN BY: Nouran Amin

The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the McGill University Health Centre (RI-MUHC), the Montreal Children's Hospital of the MUHC (MCH-MUHC), and McGill University in collaboration with French teams from AP-HP, Inserm, Université Paris-Descartes and the Imagine Institute at the Necker-Enfants Malades Hospital, have shed new light on a molecule called TIM-3 which may be implicated in the regulation of immune responses.

Credit: McGill University Health Centre via MedicalXpress.com

Tenzin Gayden (co-first author) in Dr. Jabado's laboratory at the Research Institute of the McGill University Health Centre in Montreal. -MedicalXpress

“The results of this collaboration demonstrate the regulatory role of the TIM-3 molecule in humans and they also provide strong arguments for reconsidering this entity as an inflammatory rather than a malignant pathology, and for promoting the use of immunosuppressive drugs in its treatment," explains Dr. Geneviève de Saint Basile.

According to the study published in journal Nature Genetics, the researchers have identified TIM-3 as a potential target for immunotherapeutic treatments in patients with cancer and other diseases. Specifically, they found that when the protein is under suppression, then immune responses become out of control and overly-activated leading to subcutaneous panniculitis T lymphoma (LTSCP), a rare form of lymphoma that starts in the lymphocytes.

Watch this short video below to learn more about Lymphoma:

They found that two forms of mutations at the origin of this syndrome that target TIM-3 protein, inhibiting it from expression on the surface of lymphocytes (T-cells)--attacking the cancer cells, thus, serving as a potential drug target. "The discovery of this mutation has shed light on a previously undescribed mechanism that allowed us to explain both the clinical presentation and the very particular evolution of these lymphomas under treatment," explains Dr. David Michonneau from the hematology-transplant service in the Saint-Louis AP-HP hospital.

The mutations have also been found in individuals of East Asian, Australian, and Polynesian origin as well as in patients of European origin. "For these patients with this rare form of lymphoma, our results reinforce the use of immunosuppressive therapies that will provide much better results and fewer side effects than cytotoxic chemotherapy," states Dr. Nada Jabado, professor of Pediatrics and Human Genetics at McGill University in Montreal.

Researchers are hopeful to use their study to see if a drug target, where TIM-3 is implicated, can help patients with other autoimmune diseases such as lupus, infectious diseases such as HIV or even malaria and multiple sclerosis.

Source: McGill University Health Centre

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 14, 2020
Chemistry & Physics
Why Are There So Few Black People in STEM?
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUN 30, 2020
Health & Medicine
UK Loosens Regulation on Prescription CBD for Epilepsy
JUN 30, 2020
UK Loosens Regulation on Prescription CBD for Epilepsy
Epidyolex-the epilepsy drug that contains the non-psychoactive cannabis chemical cannabidiol, or CBD-has been changed fr ...
JUL 20, 2020
Cancer
Fighting Cancer with Black Pepper
JUL 20, 2020
Fighting Cancer with Black Pepper
In the never-ending search for the next treatment or cure, many researchers turn towards nature. The study of black pepp ...
JUL 19, 2020
Neuroscience
Eating Fish May Protect Brain from Air Pollution
JUL 19, 2020
Eating Fish May Protect Brain from Air Pollution
Researchers have found that a diet high in omega-3 fatty acids may prevent neurodegeneration among older women living in ...
JUL 31, 2020
Drug Discovery & Development
Researchers Reverse Advanced Alzheimer's in Mice
JUL 31, 2020
Researchers Reverse Advanced Alzheimer's in Mice
Researchers from Macquarie University have found a way to reverse the effects of memory loss in mice with advanced demen ...
AUG 07, 2020
Chemistry & Physics
Excipients: "Inactive" Drug Components Could Be Functioning Beyond Their Scopes
AUG 07, 2020
Excipients: "Inactive" Drug Components Could Be Functioning Beyond Their Scopes
Excipients are chemical additives to medications. They are incorporated into all kinds of pharmaceuticals to fulfil ...
Loading Comments...